AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35652703 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine treatment + escitalopram
Number of subjects: 131
Study 35652703 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine treatment + pramipexole
Number of subjects: 131
Study 35652703 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine treatment + transcranial magnetic stimulation (TMS)
Number of subjects: 131
Study 35652703 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 131
Study 32852600 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 131
Study 32852600 — intervention group
Group type: COMPARATOR
Intervention: Conventional instrumentation (CI)
Number of subjects: 131
Study 36155390 — intervention group
Group type: EXPERIMENTAL
Intervention: Online antenatal education
Number of subjects: 44
Study 34016442 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical tests for interaction
Number of subjects: 1000
Study 34016442 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical analyses of randomized controlled trials
Number of subjects: 1000
Study 32713062 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG + EE
Number of subjects: 80
Study 32713062 — intervention group
Group type: COMPARATOR
Intervention: LNG only
Number of subjects: 80
Study 36183105 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model based on logistic regression for predicting delirium risk.
Number of subjects: 838
Study 36183105 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model based on logistic regression for predicting delirium risk (validation set).
Number of subjects: 838
Study 36183105 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent risk factors identified: CPB duration (OR 1.004, p=0.018), postoperative serum sodium (OR 1.112, p=0.001), age (OR 1.027, p=0.011), postoperative MV (OR 1.019, p=0.001).
Number of subjects: 838
Study 36183105 — intervention group
Group type: EXPERIMENTAL
Intervention: Hosmer‐Lemeshow goodness of fit test for the model.
Number of subjects: 838
Study 34271125 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger females (18–47 years)
Number of subjects: 23725
Study 34271125 — intervention group
Group type: COMPARATOR
Intervention: Older females (≥53 years)
Number of subjects: 23725
Study 34271125 — intervention group
Group type: COMPARATOR
Intervention: Older males
Number of subjects: 23725
Study 32871701 — intervention group
Group type: EXPERIMENTAL
Intervention: Family‐Focused Treatment for Childhood Depression (FFT‐CD)
Number of subjects: 134
Study 32871701 — intervention group
Group type: COMPARATOR
Intervention: Individual supportive psychotherapy (IP)
Number of subjects: 134
Study 35444121 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 32980866 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 16
Study 32980866 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 16
Study 32980866 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint Interval Exercise (SIE)
Number of subjects: 16
Study 33726804 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide (Xtandi®) 160 mg (4x40 mg) daily for five consecutive days
Number of subjects: 600
Study 33726804 — intervention group
Group type: COMPARATOR
Intervention: Standard of care treatment for patients hospitalised with COVID‐19
Number of subjects: 600
Study 32875505 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated clinical prediction rule (iCPR) system for antibiotic prescribing in ARIs
Number of subjects: 541
Study 32875505 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 541
Study 32875505 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated clinical prediction rule (iCPR) system
Number of subjects: 541
Study 34799191 — intervention group
Group type: EXPERIMENTAL
Intervention: Escape room approach (EG)
Number of subjects: 248
Study 34799191 — intervention group
Group type: COMPARATOR
Intervention: Traditional-based teaching approach (CG)
Number of subjects: 248
Study 33664429 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-7 375 µg daily
Number of subjects: 148
Study 33664429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 32049562 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (30 maximum inspirations at 50% PImax, twice per day, 6 days per week)
Number of subjects: 19
Study 32049562 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Number of subjects: 19
Study 32049562 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 616788544 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/4 roasted chickpea flour bread
Number of subjects: 10
Study 616788544 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/2 roasted chickpea flour bread
Number of subjects: 10
Study 616788544 — intervention group
Group type: EXPERIMENTAL
Intervention: roasted chickpea flour breads
Number of subjects: 10
Study 34486714 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp-based intervention with up to 4 physical activity promotion messages per week for 10 weeks
Number of subjects: 110
Study 34486714 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp-based intervention
Number of subjects: 110
Study 32898517 — intervention group
Group type: EXPERIMENTAL
Intervention: Battling rope (BTR) exercise
Number of subjects: 11
Study 32898517 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control trial
Number of subjects: 11
Study 35357564 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopaminergic medication
Number of subjects: 63
Study 35357564 — intervention group
Group type: COMPARATOR
Intervention: OFF medication (PD patients)
Number of subjects: 63
Study 32717926 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol consumption (35 g daily for eight weeks)
Number of subjects: 0
Study 32717926 — intervention group
Group type: COMPARATOR
Intervention: Ethanol-free control (CTL) group
Number of subjects: 0
Study 33687323 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBTi) and manual standardized stress acupuncture (MSSA)
Number of subjects: 0
Study 33687323 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy for insomnia (CBTi) only
Number of subjects: 0
Study 35398450 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch (SEE)
Number of subjects: 50
Study 35398450 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective enamel etching + self-etch (SET)
Number of subjects: 50
Study 35398450 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch-and-rinse with dry dentin (ERDry)
Number of subjects: 50
Study 35398450 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch-and-rinse with wet dentin (ERWet)
Number of subjects: 50
Study 33714975 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term application of 6-thioguanine (6-TG)
Number of subjects: 3983
Study 35767586 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-selective screening strategy
Number of subjects: 326
Study 35767586 — intervention group
Group type: COMPARATOR
Intervention: Selective screening strategy
Number of subjects: 326
Study 33183574 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (transcranial direct current stimulation) along with a hypocaloric diet (HD)
Number of subjects: 28
Study 33183574 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (placebo) along with a hypocaloric diet (HD)
Number of subjects: 28
Study 33183574 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (transcranial direct current stimulation)
Number of subjects: 28
Study 34390923 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric mSIT cycling (CON)
Number of subjects: 25
Study 34390923 — intervention group
Group type: COMPARATOR
Intervention: Eccentric mSIT cycling (ECC)
Number of subjects: 25
Study 32471328 — intervention group
Group type: EXPERIMENTAL
Intervention: DRSP/20EE
Number of subjects: 78
Study 32471328 — intervention group
Group type: EXPERIMENTAL
Intervention: DRSP/30EE
Number of subjects: 78
Study 32471328 — intervention group
Group type: COMPARATOR
Intervention: Control (not using oral contraceptives)
Number of subjects: 78
Study 36216658 — intervention group
Group type: EXPERIMENTAL
Intervention: Niraparib 300 or 200 mg daily plus best supportive care (BSC)
Number of subjects: 58
Study 36216658 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 58
Study 36216658 — intervention group
Group type: EXPERIMENTAL
Intervention: Niraparib plus BSC
Number of subjects: 58
Study 36216658 — intervention group
Group type: COMPARATOR
Intervention: BSC alone
Number of subjects: 58
Study 32122822 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermodilution-derived temperature recovery time (TRT) measured immediately post PCI.
Number of subjects: 271
Study 32359738 — intervention group
Group type: EXPERIMENTAL
Intervention: Even dietary advice strategy
Number of subjects: 60
Study 32359738 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak dietary advice strategy
Number of subjects: 60
Study 32359738 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 35902157 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744
Study 35902157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study 35504836 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention that increased vegetable intake
Number of subjects: 387
Study 34096641 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-led cognitive behavioural therapy (From Timid to Tiger), 8 sessions
Number of subjects: 71
Study 34096641 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 71
Study 36256505 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-90001 (10–720 mg single dose or 30–480 mg once daily for 7–18 days)
Number of subjects: 184
Study 36256505 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-90001
Number of subjects: 184
Study 36256505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study 33971928 — intervention group
Group type: EXPERIMENTAL
Intervention: Music exercise therapy
Number of subjects: 81
Study 33971928 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation therapies
Number of subjects: 81
Study 33971928 — intervention group
Group type: COMPARATOR
Intervention: Music exercise without music
Number of subjects: 81
Study 35962638 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 µg/kg of intranasal desmopressin acetate
Number of subjects: 120
Study 35962638 — intervention group
Group type: COMPARATOR
Intervention: 1 mL/kg of intranasal sodium chloride 0.65% (placebo)
Number of subjects: 120
Study 33065164 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic model for predicting deterioration in health-related quality of life (dHRQoL) based on 12/87 selected variables related to chronic conditions, medication, functional status, well-being, and HRQoL.
Number of subjects: 3582
Study 32817632 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% N,N‐diethylbenzamide w/w cream distributed by village health volunteers (VHVs)
Number of subjects: 32194
Study 34489292 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes (PROs) as primary outcomes
Number of subjects: 303
Study 34489292 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes (PROs) as secondary outcomes
Number of subjects: 303
Study 34489292 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-Form 36 (SF-36) as the most used PRO
Number of subjects: 303
Study 34489292 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical methods for analysis of PROs
Number of subjects: 303
Study 37340514 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional autologous PRP plus classic topical treatment
Number of subjects: 94
Study 37340514 — intervention group
Group type: COMPARATOR
Intervention: Topical compounds only
Number of subjects: 94
Study 32723508 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Fat High Carbohydrate Control (LFHCC) diet
Number of subjects: 462
Study 32723508 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 462
Study 32723508 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathways analysis
Number of subjects: 462
Study 32668588 — intervention group
Group type: EXPERIMENTAL
Intervention: HP‐MCHO (high-protein/moderate carbohydrate) meal
Number of subjects: 14
Study 32668588 — intervention group
Group type: COMPARATOR
Intervention: LP‐HCHO (low-protein/high-carbohydrate) meal
Number of subjects: 14
Study 32668588 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard breakfast after night meal
Number of subjects: 14
Study 33511686 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (single infusion)
Number of subjects: 46
Study 32546253 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted recruitment methods
Number of subjects: 0
Study 32546253 — intervention group
Group type: COMPARATOR
Intervention: Non-targeted recruitment methods
Number of subjects: 0
Study 32546253 — intervention group
Group type: EXPERIMENTAL
Intervention: Both recruitment methods
Number of subjects: 0
Study 35751042 — intervention group
Group type: EXPERIMENTAL
Intervention: LASIK Xtra
Number of subjects: 25
Study 35751042 — intervention group
Group type: COMPARATOR
Intervention: convLASIK
Number of subjects: 25
Study 36117310 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic inflammation (SI) with LPS injections (1 ng/kg and 0.5 ng/kg)
Number of subjects: 8
Study 36117310 — intervention group
Group type: COMPARATOR
Intervention: Healthy conditions (HC)
Number of subjects: 8
Study 34273115 — intervention group
Group type: EXPERIMENTAL
Intervention: BUYOI-AI
Number of subjects: 497
Study 34273115 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 497
Study 33463774 — intervention group
Group type: EXPERIMENTAL
Intervention: Splinted crowns (n = 11)
Number of subjects: 20
Study 33463774 — intervention group
Group type: COMPARATOR
Intervention: Non-splinted crowns (n = 13)
Number of subjects: 20
Study 33453708 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted percutaneous vertebroplasty (PVP) under local anaesthesia
Number of subjects: 30
Study 33453708 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 30
Study 34860732 — intervention group
Group type: EXPERIMENTAL
Intervention: PwCOVID
Number of subjects: 75
Study 34860732 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 75
Study 33534818 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined protocol using an optimised MUAC-based dose of ready-to-use therapeutic food (RUTF)
Number of subjects: 850
Study 33534818 — intervention group
Group type: COMPARATOR
Intervention: Standard care using weight-based RUTF rations for SAM and ready-to-use supplementary food (RUSF) for MAM
Number of subjects: 850
Study 33534818 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined protocol
Number of subjects: 850
Study 33534818 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 850
Study 35522238 — intervention group
Group type: EXPERIMENTAL
Intervention: User-centered reports
Number of subjects: 456
Study 35522238 — intervention group
Group type: COMPARATOR
Intervention: Control reports from a United Kingdom national genomic laboratory hub
Number of subjects: 456
Study 33422245 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio‐Manguinhos‐Fiocruz standard dose
Number of subjects: 960
Study 33422245 — intervention group
Group type: COMPARATOR
Intervention: Bio‐Manguinhos‐Fiocruz fractional dose
Number of subjects: 960
Study 33422245 — intervention group
Group type: EXPERIMENTAL
Intervention: Chumakov Institute of Poliomyelitis and Viral Encephalitides standard dose
Number of subjects: 960
Study 33422245 — intervention group
Group type: COMPARATOR
Intervention: Chumakov Institute of Poliomyelitis and Viral Encephalitides fractional dose
Number of subjects: 960
Study 33422245 — intervention group
Group type: EXPERIMENTAL
Intervention: Institut Pasteur Dakar standard dose
Number of subjects: 960
Study 33422245 — intervention group
Group type: COMPARATOR
Intervention: Institut Pasteur Dakar fractional dose
Number of subjects: 960
Study 33422245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanofi Pasteur standard dose
Number of subjects: 960
Study 33422245 — intervention group
Group type: COMPARATOR
Intervention: Sanofi Pasteur fractional dose
Number of subjects: 960
Study 34059348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (3 standardized CBT‐based sessions in the 6–12 weeks post‐chemotherapy)
Number of subjects: 107
Study 34059348 — intervention group
Group type: COMPARATOR
Intervention: Control (standard of care)
Number of subjects: 107
Study 32321161 — intervention group
Group type: EXPERIMENTAL
Intervention: High Breakfast (HBR) group, n=12, protein intake at breakfast: 0.33 g/kg BW, lunch: 0.46 g/kg BW, dinner: 0.48 g/kg BW, total daily protein intake: 1.30 g/kg BW/d
Number of subjects: 26
Study 32321161 — intervention group
Group type: COMPARATOR
Intervention: Low Breakfast (LBR) group, n=14, protein intake at breakfast: 0.12 g/kg BW, lunch: 0.45 g/kg BW, dinner: 0.83 g/kg BW, total daily protein intake: 1.30 g/kg BW/d
Number of subjects: 26
Study 33246497 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 0
Study 33246497 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection
Number of subjects: 0
Study 33246497 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injection (placebo)
Number of subjects: 0
Study 35232509 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 80
Study 35232509 — intervention group
Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 80
Study 34348947 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic model developed using individual participant data from four cluster-randomised trials.
Number of subjects: 0
Study 34348947 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal-external cross-validation (IECV) of the prognostic model.
Number of subjects: 0
Study 34348947 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictor effect heterogeneity and differing baseline risk.
Number of subjects: 0
Study 616063448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral breast tumor recurrence (IBTR)
Number of subjects: 1975
Study 616063448 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary tumor characteristics (T size, nodal status)
Number of subjects: 1975
Study 616063448 — intervention group
Group type: EXPERIMENTAL
Intervention: ER-negative cohort
Number of subjects: 1975
Study 616063448 — intervention group
Group type: COMPARATOR
Intervention: IBTR occurrence
Number of subjects: 1975
Study 36435148 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror Exposure (ME)
Number of subjects: 76
Study 36435148 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring (CR)
Number of subjects: 76
Study 36435148 — intervention group
Group type: COMPARATOR
Intervention: Wait-list Control Group (WCG)
Number of subjects: 76
Study 34656876 — intervention group
Group type: EXPERIMENTAL
Intervention: Aviandr 40 mg daily
Number of subjects: 129
Study 34656876 — intervention group
Group type: EXPERIMENTAL
Intervention: Aviandr 60 mg daily
Number of subjects: 129
Study 34656876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 34656876 — intervention group
Group type: EXPERIMENTAL
Intervention: Aviandr (both doses)
Number of subjects: 129
Study 32375499 — intervention group
Group type: EXPERIMENTAL
Intervention: Low biosecurity measures
Number of subjects: 13
Study 32375499 — intervention group
Group type: COMPARATOR
Intervention: Higher biosecurity levels and proper management
Number of subjects: 13
Study 32375499 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of basic biosecurity measures
Number of subjects: 13
Study 35650583 — intervention group
Group type: EXPERIMENTAL
Intervention: Home gardening and nutrition counseling intervention (bio-diversification of horticultural home gardens and nutritional health counseling using WHO's 7 Essential Nutrition Action messages)
Number of subjects: 1200
Study 35650583 — intervention group
Group type: EXPERIMENTAL
Intervention: Home gardening and nutrition counseling intervention
Number of subjects: 1200
Study 35650583 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 1200
Study 33325010 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 15
Study 33325010 — intervention group
Group type: COMPARATOR
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 15
Study 34783456 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic budesonide nasal spray (256 μg)
Number of subjects: 32
Study 34783456 — intervention group
Group type: COMPARATOR
Intervention: Branded budesonide nasal spray (256 μg)
Number of subjects: 32
Study 34074263 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized test‐treatment studies
Number of subjects: 0
Study 34074263 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size re‐estimation based on a nuisance parameter
Number of subjects: 0
Study 34074263 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive designs within randomized test‐treatment studies
Number of subjects: 0
Study 34806941 — intervention group
Group type: EXPERIMENTAL
Intervention: Student-led (autonomous) HIIT condition
Number of subjects: 402
Study 34806941 — intervention group
Group type: COMPARATOR
Intervention: Teacher-led (non-autonomous) HIIT condition
Number of subjects: 402
Study 35562781 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial navigation intervention (brief: one cycle, Arm 2; extended: three cycles, Arm 3)
Number of subjects: 0
Study 35562781 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (comparison group, Arm 1)
Number of subjects: 0
Study 32394880 — intervention group
Group type: EXPERIMENTAL
Intervention: V180 nonadjuvanted (N = 8)
Number of subjects: 20
Study 32394880 — intervention group
Group type: EXPERIMENTAL
Intervention: V180 adjuvanted with Alhydrogel™ (N = 8)
Number of subjects: 20
Study 32394880 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 4)
Number of subjects: 20
Study 32394880 — intervention group
Group type: EXPERIMENTAL
Intervention: V180 vaccine
Number of subjects: 20